Compare · AVTR vs DHR
AVTR vs DHR
Side-by-side comparison of Avantor Inc. (AVTR) and Danaher Corporation (DHR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both companies sit in the Industrials sector. AVTR focuses on Biotechnology: Laboratory Analytical Instruments, while DHR focuses on Industrial Machinery/Components.
- DHR is the larger of the two at $165.55B, about 15.5x AVTR ($10.66B).
- DHR has been more active in the news (18 items in the past 4 weeks vs 8 for AVTR).
- Both have 25 recent analyst ratings on file.
- Company
- Avantor Inc.
- Danaher Corporation
- Price
- -
- -
- Market cap
- $10.66B
- $165.55B
- 1M return
- -
- +5.44%
- 1Y return
- -
- +7.19%
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 8
- 18
- Recent ratings
- 25
- 25
Avantor Inc.
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Latest AVTR
- EVP, Chief Legal & Compliance Sokenu Claudius was granted 62,305 shares, increasing direct ownership by 25% to 313,533 units (SEC Form 4)
- EVP, Chief HR Officer Hankamer Brittany was granted 46,728 shares, increasing direct ownership by 19% to 295,592 units (SEC Form 4)
- Avantor Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 10-Q filed by Avantor Inc.
- SEC Form 8-K filed by Avantor Inc.
- Avantor® Reports Third Quarter 2026 Results
- Avantor appoints new Chief Information Officer
- Healthcare Stocks Rushing Higher, with Oncology Push, Breakout Test, and Lilly’s Next Growth Chapter
- Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026
- EVP and CFO Garner Todd W was granted 49,688 shares (SEC Form 4)
Latest DHR
- Executive Vice President Milosevich Gregory M sold $484,302 worth of shares (2,100 units at $230.62), decreasing direct ownership by 9% to 22,367 units (SEC Form 4)
- Executive Vice President Mcgrew Matthew exercised 17,385 shares at a strike of $88.24 and sold $4,097,452 worth of shares (17,385 units at $235.69) (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Danaher Corporation
- Why the Next Edge in Antibody Discovery May Be What Labs Remember
- Integrated DNA Technologies and Aldevron Launch New mRNA Solutions to Simplify Base and Prime Editing
- Director Dewan Feroz was granted 144 phantom shares (SEC Form 4)
- Director Zerhouni Elias A. was granted 199 phantom shares (SEC Form 4)
- Director Filler Linda was granted 15 phantom shares (SEC Form 4)
- Director Stevens Raymond C was granted 153 phantom shares (SEC Form 4)
- Director List Teri was granted 13 phantom shares (SEC Form 4)